SciSparc Ltd. — Investor Relations & Filings
Filings indexed
554
across all filing types
Latest filing
2025-12-31
Foreign Filer Report
Country
US
United States of America
Listing
US
SPRC
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company that develops therapies for central nervous system (CNS) disorders. The company focuses on creating and enhancing a portfolio of technologies and assets based on proprietary cannabinoid pharmaceuticals. Its drug development pipeline includes candidates in clinical and pre-clinical stages targeting conditions such as Tourette Syndrome, Autism Spectrum Disorder, Alzheimer's disease and agitation, Obstructive Sleep Apnea, Status Epilepticus, and chronic pain. SciSparc's approach utilizes the biochemistry of receptors that modulate the central nervous system to create its therapeutic compounds.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-31 | English | |
| POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1 | 2025-12-23 | English | |
| Major Shareholding Notification 2025 | 2025-12-11 | English | |
| Major Shareholding Notification 2025 | 2025-12-11 | English | |
| Major Shareholding Notification 2025 | 2025-12-04 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-02 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 12795689 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-31 | English | ||
| 12795690 | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1 | 2025-12-23 | English | ||
| 12795692 | Major Shareholding Notification 2025 | 2025-12-11 | English | ||
| 12795691 | Major Shareholding Notification 2025 | 2025-12-11 | English | ||
| 12795693 | Major Shareholding Notification 2025 | 2025-12-04 | English | ||
| 12795695 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-02 | English | ||
| 12795696 | PROSPECTUS SUPPLEMENT | 2025-11-28 | English | ||
| 12795694 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-28 | English | ||
| 12795697 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-26 | English | ||
| 12795698 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-20 | English | ||
| 12795699 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-18 | English | ||
| 12795701 | WITHDRAWAL REQUEST | 2025-11-04 | English | ||
| 12795700 | PROSPECTUS SUPPLEMENT | 2025-11-04 | English | ||
| 12795702 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-10-27 | English | ||
| 12795703 | Major Shareholding Notification 2025 | 2025-10-24 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SciSparc Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35501/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35501 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35501 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35501 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35501}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SciSparc Ltd. (id: 35501)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.